S. 2295, H.R. 4384 and related legislation regarding pharmaceutical labeling changes Issues related to implementation of US-Korea Free Trade Agreement
Issues related to trade protection in Trans Pacific Partnership
Issues related to trade liberalization between US and European Union Issues related to reform of tax code and possible timing of any such reform bill (no bill number yet)
H.R. 6353 - issues related to tax incentives for manufacturing HR 2182, S1734, and S2187 (as passed in Pub. L. No. 112-144)  issues related to the development of antibiotics
H.R. 6353 - issues related to providing intelletual property incentives for manufacturing
H.R. 6502 - issues related to the provision on incentives for development of medicines for life-threatening illnesses HR 2182, S1734, and S2187 (as passed in Pub. L. No. 112-144)  issues related to the development of antibiotics
H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumerHR 1483 - issues related to drug safety, supply chain, and facility inspections
H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting
H.R. 3668 issues related to increased penalties for counterfeiting drugs
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to 340B program amendments and implementation of statutory changes.
HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to definition of essential health benefits and health insurance exchanges.
HR 6160 - issues related to drug safety issues, including tamper resistent packaging
HR 1513 - issues related to animal research
HR 6502 - issues related to development of medicines for life-threatening illnesses
HR 3497 - issues related to incentives for developing and improving diagnostic tests and related treatments
HR 6272 - issues related to the expansion of clinical trial data banks and increase government reporting of same
HR 6163 - issues related to incentives for increased research into pediatric treatments HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to Medicare and Medicaid reform, including possible changes to Part D and changes to Medicaid price reporting requirements.
HR 2190, S 1206 and related legislative proposals regarding changes/scope of Medicare Part D rebates
HR 5979 - issues related to proposed changes in Medicaid payments H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer
HR 1483  issues related to drug safety, supply chain, and facility inspectionsH.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting
H.R. 3668 issues related to increased penalties for counterfeiting drugs
H.R. 6160 - issues related to drug safety, including tamper resistent packaging
PHA - Pharmacy TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid CSP - Consumer Issues/Safety/Products
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR) 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 22 - U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP
1800 CONCORD PIKE, P.O. BOX 15437, WILMINGTON, DE, 19850, US
HEATHER STRAWN ANDREW KAPLAN BRADLEY ALLEN ROSSIN ANDREW KAPLAN HEATHER STRAWN ANDREW KAPLAN HEATHER STRAWN CARRIE HARNEY THERESA JOLIVETTE ANDREW KAPLAN HEATHER STRAWN BELA SASTRY CARRIE HARNEY THERESA JOLIVETTE ANDREW KAPLAN BELA SASTRY HEATHER STRAWN CARRIE HARNEY THERESA JOLIVETTE ANDREW KAPLAN HEATHER STRAWN BELA SASTRY